Retraction notice to "Therapeutic role of enoxaparin in intra-uterine growth restriction: A randomized clinical trial" [J Gynecol Obstet Hum Reprod (2021) 102070]

J Gynecol Obstet Hum Reprod. 2025 Sep;54(7):102984. doi: 10.1016/j.jogoh.2025.102984. Epub 2025 Jun 12.

Abstract

This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/policies-and-standards/article-withdrawal). This article has been retracted at the request of the Editor-in-Chief and the journal's Ethics Committee. After post-publication investigation, issues related to the following were identified in the article: Significant inconsistencies in data reported in the article: delays between the end of inclusion and submission, table 2. To facilitate a thorough examination and ensure the accuracy of the information reported in the article, the authors were asked for the de-identified research data used in the article. In the absence of an answer from the authors, a decision to retract the article was made in accordance with the journal's commitment to upholding the highest standards of scientific integrity and accuracy in published research.

Publication types

  • Retraction Notice